【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 14
2 Introduction 15
2.1 Spinal Non-Fusion Overview 15
3 Products under Development 16
3.1 Spinal Non-Fusion – Pipeline Products by Stage of Development 16
3.2 Spinal Non-Fusion – Pipeline Products by Segment 17
3.3 Spinal Non-Fusion – Pipeline Products by Territory 18
3.4 Spinal Non-Fusion – Pipeline Products by Regulatory Path 19
3.5 Spinal Non-Fusion – Pipeline Products by Estimated Approval Date 20
3.6 Spinal Non-Fusion – Ongoing Clinical Trials 21
4 Spinal Non-Fusion – Pipeline Products under Development by Companies 22
4.1 Spinal Non-Fusion Companies – Pipeline Products by Stage of Development 22
4.2 Spinal Non-Fusion – Pipeline Products by Stage of Development 25
5 Spinal Non-Fusion Companies and Product Overview 28
5.1 ALCeraX Medizintechnik GmbH Company Overview 28
5.1.1 ALCeraX Medizintechnik GmbH Pipeline Products & Ongoing Clinical Trials Overview 28
5.2 Alphatec Holdings, Inc. Company Overview 29
5.2.1 Alphatec Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.3 Amedica Corporation Company Overview 32
5.3.1 Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview 32
5.4 Apollo Implants LLC Company Overview 35
5.4.1 Apollo Implants LLC Pipeline Products & Ongoing Clinical Trials Overview 35
5.5 ARO Medical, LLC Company Overview 36
5.5.1 ARO Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 36
5.6 Arthro Kinetics AG Company Overview 37
5.6.1 Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 37
5.7 Artimplant AB Company Overview 38
5.7.1 Artimplant AB Pipeline Products & Ongoing Clinical Trials Overview 38
5.8 Ascendx Spine, Inc. Company Overview 42
5.8.1 Ascendx Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.9 AxioMed Spine Corporation Company Overview 43
5.9.1 AxioMed Spine Corporation Pipeline Products & Ongoing Clinical Trials Overview 43
5.10 Baxano Surgical Inc Company Overview 48
5.10.1 Baxano Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 48
5.11 Chi2Gel Ltd. Company Overview 52
5.11.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 52
5.12 City University London Company Overview 53
5.12.1 City University London Pipeline Products & Ongoing Clinical Trials Overview 53
5.13 Covexus Medical Technologies, LLC Company Overview 54
5.13.1 Covexus Medical Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 54
5.14 Crocker Spinal Technologies, Inc. Company Overview 55
5.14.1 Crocker Spinal Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.15 CryoLife, Inc. Company Overview 57
5.15.1 CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.16 Curtin University Company Overview 59
5.16.1 Curtin University Pipeline Products & Ongoing Clinical Trials Overview 59
5.17 DePuy Companies Company Overview 60
5.17.1 DePuy Companies Pipeline Products & Ongoing Clinical Trials Overview 60
5.18 Disc Motion Technologies Company Overview 64
5.18.1 Disc Motion Technologies Pipeline Products & Ongoing Clinical Trials Overview 64
5.19 Elite Surgical Supplies (Pty) Limited Company Overview 68
5.19.1 Elite Surgical Supplies (Pty) Limited Pipeline Products & Ongoing Clinical Trials Overview 68
5.20 FlexSIS Ltd. Company Overview 69
5.20.1 FlexSIS Ltd. Pipeline Products & Ongoing Clinical Trials Overview 69
5.21 Flexuspine, Inc. Company Overview 70
5.21.1 Flexuspine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.22 Gentis Inc. Company Overview 71
5.22.1 Gentis Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.23 Globus Medical, Inc. Company Overview 74
5.23.1 Globus Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
5.24 Hydrospine, Inc. Company Overview 81
5.24.1 Hydrospine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.25 IB Medical AB Company Overview 82
5.25.1 IB Medical AB Pipeline Products & Ongoing Clinical Trials Overview 82
5.26 Innovia LLC Company Overview 83
5.26.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 83
5.27 Integra LifeSciences Holdings Corporation Company Overview 84
5.27.1 Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview 84
5.28 Jemo Spine, LLC. Company Overview 86
5.28.1 Jemo Spine, LLC. Pipeline Products & Ongoing Clinical Trials Overview 86
5.29 LDR Holding Corporation Company Overview 87
5.29.1 LDR Holding Corporation Pipeline Products & Ongoing Clinical Trials Overview 87
5.30 Medical University of South Carolina Company Overview 89
5.30.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 89
5.31 Medicrea International SA Company Overview 90
5.31.1 Medicrea International SA Pipeline Products & Ongoing Clinical Trials Overview 90
5.32 Medtronic plc Company Overview 95
5.32.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 95
5.33 MI4 Spine, LLC Company Overview 100
5.33.1 MI4 Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 100
5.34 MicroPort Scientific Corporation Company Overview 101
5.34.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 101
5.35 MiMedx Group, Inc Company Overview 103
5.35.1 MiMedx Group, Inc Pipeline Products & Ongoing Clinical Trials Overview 103
5.36 Nano Interface Technology, Inc. Company Overview 105
5.36.1 Nano Interface Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 105
5.37 NeuroPro Technologies, Inc. Company Overview 106
5.37.1 NeuroPro Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106
5.38 Nexgen Spine Inc. Company Overview 107
5.38.1 Nexgen Spine Inc. Pipeline Products & Ongoing Clinical Trials Overview 107
5.39 NLT Spine Company Overview 109
5.39.1 NLT Spine Pipeline Products & Ongoing Clinical Trials Overview 109
5.40 NuVasive, Inc. Company Overview 113
5.40.1 NuVasive, Inc. Pipeline Products & Ongoing Clinical Trials Overview 113
5.41 Orthonex LLC Company Overview 119
5.41.1 Orthonex LLC Pipeline Products & Ongoing Clinical Trials Overview 119
5.42 Paramount Surgicals Company Overview 122
5.42.1 Paramount Surgicals Pipeline Products & Ongoing Clinical Trials Overview 122
5.43 Precision Spine, Inc. Company Overview 125
5.43.1 Precision Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 125
5.44 Premia Spine, Ltd. Company Overview 126
5.44.1 Premia Spine, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 126
5.45 Ranier Technology Limited Company Overview 129
5.45.1 Ranier Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 129
5.46 Raymedica, LLC Company Overview 132
5.46.1 Raymedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 132
5.47 RE Spine, LLC Company Overview 134
5.47.1 RE Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 134
5.48 Reduction Technologies, Inc. Company Overview 135
5.48.1 Reduction Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
5.49 Replication Medical, Inc. Company Overview 136
5.49.1 Replication Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.50 Resoimplant GmbH (Inactive) Company Overview 137
5.50.1 Resoimplant GmbH (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 137
5.51 S14 Implants Company Overview 138
5.51.1 S14 Implants Pipeline Products & Ongoing Clinical Trials Overview 138
5.52 SeaSpine, Inc. (Inactive) Company Overview 139
5.52.1 SeaSpine, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 139
5.53 Simpirica Spine, Inc. Company Overview 140
5.53.1 Simpirica Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 140
5.54 Simplify Medical, Inc. Company Overview 142
5.54.1 Simplify Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 142
5.55 Smart Disc, Inc. Company Overview 143
5.55.1 Smart Disc, Inc. Pipeline Products & Ongoing Clinical Trials Overview 143
5.56 Spinal Kinetics Inc. Company Overview 144
5.56.1 Spinal Kinetics Inc. Pipeline Products & Ongoing Clinical Trials Overview 144
5.57 Spinalcyte Llc Company Overview 149
5.57.1 Spinalcyte Llc Pipeline Products & Ongoing Clinical Trials Overview 149
5.58 SpinalMotion, Inc. Company Overview 150
5.58.1 SpinalMotion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150
5.59 SpinalVu Inc Company Overview 157
5.59.1 SpinalVu Inc Pipeline Products & Ongoing Clinical Trials Overview 157
5.60 Spine Smith, LP Company Overview 158
5.60.1 Spine Smith, LP Pipeline Products & Ongoing Clinical Trials Overview 158
5.61 Spine Wave, Inc. Company Overview 160
5.61.1 Spine Wave, Inc. Pipeline Products & Ongoing Clinical Trials Overview 160
5.62 Spine21 Ltd. Company Overview 163
5.62.1 Spine21 Ltd. Pipeline Products & Ongoing Clinical Trials Overview 163
5.63 SpineLab AG Company Overview 164
5.63.1 SpineLab AG Pipeline Products & Ongoing Clinical Trials Overview 164
5.64 Stryker Corporation Company Overview 165
5.64.1 Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 165
5.65 Synergy Disc Replacement, Inc. Company Overview 167
5.65.1 Synergy Disc Replacement, Inc. Pipeline Products & Ongoing Clinical Trials Overview 167
5.66 Synthes, Inc. Company Overview 169
5.66.1 Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview 169
5.67 Takiron Co., Ltd. Company Overview 170
5.67.1 Takiron Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 170
5.68 TrueMotion Spine, Inc. Company Overview 172
5.68.1 TrueMotion Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 172
5.69 University of Colorado Company Overview 174
5.69.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 174
5.70 University of South Florida Company Overview 175
5.70.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 175
5.71 Vertebral Technologies, Inc. Company Overview 176
5.71.1 Vertebral Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 176
5.72 Weill Cornell Medical College Company Overview 180
5.72.1 Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview 180
5.73 X-spine Systems, Inc. Company Overview 181
5.73.1 X-spine Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 181
5.74 Zimmer Biomet Holdings, Inc. Company Overview 182
5.74.1 Zimmer Biomet Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 182
6 Spinal Non-Fusion – Recent Developments 188
7 Appendix 226
7.1 Methodology 226
7.2 About GlobalData 228
7.3 Contact Us 229
7.4 Disclaimer 229
【レポート販売概要】
■ タイトル：世界における脊椎非固定デバイスの製品パイプライン動向2015■ 英文：Spinal Non-Fusion - Pipeline Review, 2015
■ 発行日：2015年9月4日
■ 調査会社：GlobalData
■ 商品コード：GDME0066EPD
■ 調査対象地域：グローバル
- 肺線維症(Pulmonary Fibrosis)の治療薬パイプライン動向（2015年上半期版）Pulmonary Fibrosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Pulmonary Fibrosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pulmonary Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mecha …
- グローバルにおけるジメチルエーテル市場（2014-2018）About Dimethyl Ether Dimethyl Ether (DME), also known as methyl ether, is a colourless non-toxic gas which is easy to liquefy and transport. DME is a clean energy source that can be manufactured from various abundant sources including coal, biomass, and natural gas. It has a great potential for use as an alternative for transportation fuel. In addition, it is also used in power generation and dome …
- 百日咳(Pertussis)の治療薬パイプライン動向（2015年上半期版）Pertussis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Pertussis - Pipeline Review, H1 2015’, provides an overview of the Pertussis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pertussis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of admin …
- TDT-067 (Dermatophytic Onychomycosis)：市場予測と分析（～2022）TDT-067 (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “TDT-067 (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022”. Dermatophytic onychomycosis (DO) is characterized as being a fungal infection of the nail. Infection can involve the nail unit (nail matrix, nail bed, or nail plate). …
- Repsol S.A.：石油・ガスの開発・生産動向及びコスト分析– Q1, 2013Repsol S.A. Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary Repsol S.A. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational …
- ストレージ・ソフトウェアのグローバル市場動向（2014-2018）About Storage Software Storage software is an effective tool used by enterprises to improve the control and management of storage hardware devices and networks. Storage software comprises all software products that are used for efficient data management and data storage in the enterprise infrastructure. Storage software can be used for device management, data transmission, data security, data reco …
- グローバルにおける自動車向け音声認識市場（2014-2018）About Automotive Voice Recognition An automotive voice recognition system helps passengers give commands to be carried out by infotainment systems in the vehicle. These systems help the driver access various automotive systems with simple voice commands, thereby providing a user-friendly environment in the vehicle. TechNavio's analysts forecast the Global Automotive Voice Recognition market will g …
- Biliary Tract Disease：グローバル臨床試験レビューH2, 2013Biliary Tract Disease Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Biliary Tract Disease Global Clinical Trials Review, H2, 2013" provides data on the Biliary Tract Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Biliary Tract Disease. It includes an overview of the trial numbers and the …
- Victoria Oil & Gas plc社の石油・ガス開発・生産動向及びコスト分析（2013年）Victoria Oil & Gas plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2013 Summary Victoria Oil & Gas plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- 世界の受動光ネットワーク(PON)装置市場動向（2012-2016）TechNavio's analysts forecast the Global Passive Optical Network (PON) Equipment market to grow at a CAGR of 23.14 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing growth of PON equipment in China. The Global PON Equipment market has also been witnessing the development of ultra-high capacity optical networks. However, the declining ave …
- 世界のmHealth（モバイルヘルス）アプリおよびソリューション市場mHealth is a successful integration of mobile technology and healthcare services that entail a revolution in the global healthcare solutions market. The global mHealth market is estimated to be valued at $6.6 billion in 2013 and is expected to reach $20.7 billion by 2018 at a healthy CAGR of 25.5%. The mobile healthcare market is broadly categorized into connected medical device and healthcare app …
- ディーゼル燃料用添加剤の世界市場The report covers the global diesel additives market and further divides the market on the basis of type and geography. The market data for these types is given with respect to volume (kilotons) and value (USD Million). The market value of diesel fuel additives was estimated to be $3,717.7 million in 2014 and is projected to grow at a CAGR of 7.3% from 2014 to 2019. The data mentioned in the repor …
- 健康・ウェルネスの世界市場2018-2022About Health and Wellness The health and wellness products ensure complete physical, mental, and social well-being and not merely the absence of disease. These products help in weight management, improving stamina, developing muscular strength, and the overall well-being of an individual; they also help in dealing with ailments and some medical issues. Technavio’s analysts forecast the global heal …
- GIS市場動向（2012-2016）：インドTechNavio's analysts forecast the GIS market in India to grow at a CAGR of 8.19 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand from the Government sector. The GIS market in India has also been witnessing the development of next-generation systems. However, the need for high initial investment could pose a challenge to the growt …
- 航空機用燃料装置の世界市場：燃料ポンプ、燃料バルブ、燃料計、燃料制御モニタリング装置、燃料フィルターThe global aircraft fuel systems market is expected to reach USD 9,146.6 million by 2020 from USD 6,524.6 million in 2015, at a CAGR of 7.0% between 2015 and 2020. The geographic segments included in this report are Asia-Pacific, North America, Europe, The Middle East, and the Rest of the World (RoW). The aircraft fuel system market in Asia-Pacific is expected to account for the largest share of t …
